Healthtech & Wellness VC Funds

Benhamou Global Ventures (BGV) is a Silicon Valley-based venture capital firm founded by Eric Benhamou in 2004. Specializing in early-stage investments, BGV focuses on Enterprise 5.0, which combines artificial intelligence with human ingenuity to drive significant productivity improvements. Their portfolio includes notable companies like Totango, Virtana, and Grid Dynamics. BGV has a strong emphasis on cross-border innovation, sourcing startups from global innovation hubs such as France, Israel, and India. This strategy leverages the firm's deep operational expertise and global network to help startups scale in the U.S. and beyond. Approximately 60% of BGV's portfolio companies are founded outside Silicon Valley. The firm recently closed its fourth fund at $110 million, continuing its focus on ethical AI solutions that address data privacy and security concerns while avoiding biases related to race, gender, or age. BGV is committed to providing both financial and human capital, ensuring their portfolio companies receive the necessary support to grow and succeed globally. Eric Benhamou, the founder, brings over 40 years of experience in the IT industry and has participated in numerous IPOs and M&As. His extensive background includes leadership roles at 3Com and Palm, along with significant venture capital experience

Beringea is a transatlantic venture capital firm with a significant presence in the UK and the US, managing over $900 million in assets. Founded in 1988, Beringea has made a name for itself by investing in high-growth companies across sectors such as healthcare, clean technology, media, consumer services, SaaS, and technology. Notable investments from Beringea include successful exits like D3O, ContactEngine, and Inskin Media, showcasing their ability to nurture and grow impactful businesses. Their portfolio also features promising companies like MPB, Flywheel, Asterra, Moonshot, and Akadeum, which highlight their focus on innovation and scalability. Beringea’s investment strategy involves early and growth-stage funding, with typical investments ranging from $2 million to $10 million. They emphasize scalable business models targeting large markets and have a strong track record of leading funding rounds and providing significant operational support to their portfolio companies. Geographically, Beringea operates out of Farmington Hills, Michigan, and London, with additional offices and operations supporting their global reach. The firm's team includes experienced partners like Michael Gross and Stuart Veale, who bring extensive industry knowledge and leadership to the table.

Berkeley SkyDeck is UC Berkeley's premier startup accelerator, integrating the extensive resources of one of the world's top universities with a robust venture fund. Launched as a partnership between the Haas School of Business, the College of Engineering, and the Office of the Vice Chancellor for Research, SkyDeck combines traditional accelerator consulting with academic expertise and research resources​. The Berkeley SkyDeck Fund, with $85 million under management, invests in startups participating in the accelerator program and those with Berkeley affiliations. Each startup in the accelerator receives an initial investment of $200,000. The fund is known for its high activity, making over 100 investments in just three years, backed by prominent VCs like Sequoia Capital and Mayfield Fund. SkyDeck provides startups with access to a vast network of advisors, industry partners, and UC Berkeley alumni, helping them with sales, hiring, and further financing introductions. This network-driven approach has proven successful for alumni startups like DeepScribe and SuperAnnotate, which have raised significant funds and achieved substantial growth. The accelerator supports a diverse range of startups from various sectors and stages, including biotech, hardware, consumer products, and enterprise solutions. SkyDeck also emphasizes diversity, equity, and inclusion, actively working to support underrepresented founders.

Bessemer Venture Partners (BVP), headquartered in San Francisco, is one of the oldest venture capital firms in the United States. Established in 1911, BVP has a long history of investing in early- and growth-stage companies across various industries, including technology, healthcare, and consumer sectors. Some of their notable investments include Shopify, LinkedIn, DocuSign, Pinterest, and Yelp​. BVP is known for its systematic approach to venture capital, leveraging deep industry insights and a decentralized decision-making process. This allows individual partners significant autonomy to invest across different stages, industries, and geographies. The firm has offices not only in the U.S. but also in India, Israel, and the UK​. BVP has raised multiple funds over the years, including a $3.85 billion early-stage fund in 2021 and a $780 million buyout fund under BVP Forge in 2022. These funds reflect their strategy of supporting startups from inception through to growth and eventual exit​ . Their "Anti-Portfolio" is a unique feature on their website, showcasing major investment opportunities they missed, including companies like Apple and eBay, highlighting their commitment to transparency and learning from past decisions​ ​. With a focus on fostering innovation and supporting dynamic founders, Bessemer Venture Partners continues to be a significant player in the global venture capital landscape.

Beta Boom, headquartered in Salt Lake City, Utah, is a venture capital firm focused on pre-seed and seed investments in startups led by diverse and underrepresented founders. Established in 2017 by Kimmy and Sergio Paluch, Beta Boom prioritizes founders outside of the traditional Silicon Valley ecosystem, particularly women and people of color. The firm invests in companies across various sectors, including digital health, financial technology, education technology, and SaaS. Notable portfolio companies include Canopie, Valhalla Healthcare, and Bolder Money. Beta Boom provides extensive post-investment support, including weekly coaching in product development, marketing, sales, and fundraising, effectively becoming an extension of the startup teams they invest in. Beta Boom recently closed a $14.5 million Fund II, with support from partners such as Ally Bank, Pivotal Ventures, and Bank of America. This fund aims to support early-stage startups addressing the needs of fast-growing yet underserved populations. The firm emphasizes the importance of combining capital with operational expertise to help startups succeed.

B2 Capital, based in London, is a cutting-edge asset management firm that integrates advanced technology and data-driven strategies to revolutionize the fields of ESG (Environmental, Social, and Governance), fintech, supply chain, and inventory finance. With a strong emphasis on innovation, B2 Capital positions itself as a disruptor in these sectors, utilizing a highly scalable tech platform that ensures bank-grade security while delivering agile, international financial solutions. The firm's leadership team brings together over 100 years of combined experience from leading names in the investment and technology sectors. The CEO & Co-CIO, Philip Blows, has a robust background in building and scaling asset management and fintech companies, having previously taken AQRU public in the UK. Co-CIO Dr. Philipp Kallerhoff, with his extensive experience in managing hedge funds and fintech enterprises, adds significant depth to B2 Capital's strategic capabilities. B2 Capital’s investment philosophy is centered around fostering "Diversity of Thought," aiming to deliver excellence to both clients and investors by identifying and funding innovative solutions that address global challenges, particularly in fintech and ESG. The firm’s approach is rooted in a strong commitment to creating the 'what next' in financing solutions, leveraging its advanced infrastructure to disrupt traditional finance models and promote sustainable growth. The firm’s dedication to innovation and its strategic focus on high-impact sectors position B2 Capital as a leader in the next generation of asset management.

Betaworks is a product-focused, seed-stage venture capital firm based in New York City and San Francisco. Founded by John Borthwick, the firm invests in pre-seed and seed-stage startups, typically with check sizes ranging from $250,000 to $750,000. Betaworks is known for its thematic approach, immersing itself in emerging technologies and user behaviors to identify and nurture high-potential startups. Betaworks has built and invested in notable companies such as Giphy, Dots, bitly, Tweetdeck, and Chartbeat. Their investments also include Twitter, Tumblr, Kickstarter, Medium, Hugging Face, and RecRoom. The firm operates Betaworks Camp, a cohort-based investment and product development program that delves into specific tech themes such as AI, gaming, and decentralization. The team at Betaworks includes John Borthwick, Jordan Crook, and Jonathan Chin, among others, who bring extensive experience in technology, media, and venture capital. Betaworks continues to foster innovation through its community-focused initiatives and strategic investments in the latest technological trends.

Betaworks Ventures is a product-focused, seed-stage venture capital firm based in New York City and San Francisco. Founded in 2008, Betaworks Ventures has invested in numerous innovative companies, particularly in the fields of artificial intelligence (AI), machine learning (ML), and software as a service (SaaS). Their typical investment range is between $250,000 and $750,000​​. Some of their notable investments include companies like Giphy, the popular GIF-sharing platform; Hugging Face, known for its AI-driven natural language processing tools; and Stability AI, a leader in generative AI technologies. Betaworks Ventures has also been involved in successful exits such as Shine, an app focused on mental health and wellness, and 8th Wall, a company specializing in augmented reality. Betaworks Ventures is known for its thematic investment approach, often immersing itself in emerging technologies and trends to better understand new user behaviors. This allows them to strategically invest in early-stage startups that are poised to shape the future of their respective industries​. The firm was founded by John Borthwick, who continues to lead the team along with partners like Matt Hartman and Peter Rojas. Their collective expertise and deep involvement in the tech ecosystem enable them to provide not just capital, but also valuable mentorship and support to their portfolio companies​​.

Bethnal Green Ventures (BGV), founded in 2012 and based in London, is Europe's leading early-stage tech for good venture capital firm. BGV invests in ambitious teams using technology to tackle pressing social and environmental challenges. They have backed 177 ventures so far, with notable companies like Chatterbox, LettUs Grow, and Bright Little Labs in their portfolio. These investments have collectively impacted the lives of 17 million people and generated £80 million in sales of tech for good products and services in 2022. BGV's investment strategy focuses on sectors such as HealthTech, Sustainability Tech, and Enterprise Applications, with most of their investments being in the United Kingdom. They provide initial funding of £60,000 for a 7% equity stake through their Tech for Good programme, which includes six weeks of workshops and bespoke coaching. They also offer follow-on funding from pre-seed to Series A for the most promising ventures. BGV has a strong commitment to diversity, aiming for at least half of their investments to be in ventures founded by women. They are also the first UK VC to certify as a B Corp, reflecting their dedication to transparency and ethical practices.

Better Capital is a global venture capital firm that invests in early-stage startups across a variety of sectors. Founded by Vaibhav Domkundwar, the firm has a robust portfolio with over 200 companies, a combined valuation exceeding $7 billion, and two unicorns. They focus on backing bold innovators from day zero, emphasizing a conviction-driven investment approach. The firm has notable investments in fintech, health tech, SaaS, and digital education, with significant companies like Slice, Open, and Teachmint. Better Capital typically invests in pre-seed and seed rounds, with check sizes ranging from $300K to $1M. Their portfolio also includes companies like Rupeek, Khatabook, and Yulu, which are leaders in their respective fields. Geographically, Better Capital has a strong presence in India and the United States, with investments also spread across Singapore, the UK, and Australia. The team comprises experienced professionals who have founded, grown, and sold tech startups, providing valuable mentorship and support to the companies they invest in. Startups looking to engage with Better Capital should demonstrate innovative solutions with potential for significant impact and growth. The firm values mission-driven founders and aims to support them in creating industry-defining changes.

Better Tomorrow Ventures (BTV) is a San Francisco-based venture capital firm focused on pre-seed and seed-stage investments in fintech companies globally. Founded by Jake Gibson and Sheel Mohnot, BTV leverages their extensive experience and networks in the fintech industry to support startups with ideation, key hires, customer introductions, and fundraising. They lead rounds with check sizes ranging from $500k to $3 million and manage $225 million in assets under management (AUM). BTV has invested in over 100 fintech companies, collaborating with top-tier VCs. Their portfolio includes notable companies like Albert, Lattice, Mercury, Ironclad, Flexport, and Ramp. They emphasize being hands-on partners, offering not just capital but also strategic guidance and operational support to help founders build successful companies. The team at BTV includes experienced operators who have built and exited startups themselves, bringing deep industry knowledge and a passion for fintech. This commitment to early-stage fintech innovation makes BTV a prominent player in the venture capital landscape​.

Better Ventures is a mission-driven VC firm investing in early-stage startups that harness cutting-edge technology to address pressing global challenges. Their notable investments include Meati, a sustainable protein innovator, and SMBX, a platform democratizing business financing. With a focus on sectors like climate tech, human health, and equitable economies, they back diverse teams aligned with the UN's Sustainable Development Goals. Based in Oakland, Better Ventures leads seed rounds, providing active support for founders committed to making a measurable impact. The team looks for companies that can scale profitably while driving social and environmental change, ensuring purpose and profit go hand-in-hand. Better Ventures prefers founders who blend technological innovation with a clear mission. They typically write checks of $500k to $1 million and often lead or co-lead rounds. The firm emphasizes strong partnerships, working closely with founders to scale their impact. Startups should approach Better Ventures with a well-defined purpose, as they prioritize purpose-driven innovation. The founding team includes Rick Moss and Jenny Kassan, both seasoned in impact investing and business development. Better Ventures' geographic focus spans the U.S., especially targeting hubs of innovation. Their approach to funding emphasizes scalability, sustainability, and measurable impact, creating value for both investors and society.

Beyond Next Ventures, founded in 2014 and based in Tokyo, focuses on early-stage investments in deep tech startups, primarily in Japan and India. The firm invests in various sectors including medtech, healthcare, biotechnology, agriculture, food, digital, space, and climate technology​. Notable investments include companies like MediBuddy, GigIndia, QD Laser, and Susmed. MediBuddy is a significant player in telemedicine and healthcare services in India, while QD Laser and Susmed are notable for their IPOs on the Tokyo Stock Exchange​. Beyond Next Ventures typically leads early-stage financing rounds, offering extensive support through their incubator programs aimed at commercializing advanced research. The firm has about $340 million under management, underscoring its commitment to fostering innovation in deep tech and science-based startups​. The leadership team, including CEO Tsuyoshi Ito and Managing Director Kengo Ueha, brings a wealth of experience and strategic insight, supporting startups through growth management, market entry, and expansion strategies.

BGF (Business Growth Fund) is one of the most active equity investors in the UK and Ireland, offering long-term, minority equity investments to ambitious small and mid-sized businesses. Established in 2011, BGF has invested nearly £4 billion across over 900 companies, spanning a wide range of industries, including healthcare, technology, climate sustainability, retail, and advanced manufacturing. Their portfolio includes well-known brands such as Plant-Ex and RSK Group. BGF’s strategy focuses on providing patient capital, meaning they support businesses over the long term without taking a controlling stake. They typically invest between £2 million and £20 million, with the flexibility to provide follow-on funding to drive further growth. BGF is committed to partnering with management teams across the UK and Ireland, using their regional offices to maintain close relationships with portfolio companies. With a significant emphasis on value creation, BGF supports its businesses with expertise in scaling operations, improving governance, and expanding into new markets. Their portfolio spans a wide range of sectors, from deep tech and life sciences to climate-focused companies, reflecting BGF’s commitment to fostering sustainable, scalable growth across the economy.

Bharat Fund, also known as Bharat Innovation Fund, is a venture capital firm based in India that focuses on early-stage investments in deep-tech and IP-driven startups. Founded under the aegis of CIIE.CO at IIM Ahmedabad, the fund aims to support companies that provide innovative solutions in sectors such as healthcare, agriculture, renewable energy, and advanced technology. The fund typically invests in pre-Series A and Series A stages, providing not just capital but also strategic insights, market development support, and access to extensive networks to help startups scale effectively. Bharat Fund’s mission is to back transformative entrepreneurs who are addressing some of the toughest global challenges, with the goal of turning their ventures into globally competitive and disruptive companies. Bharat Fund’s portfolio includes startups that are leveraging technology to create significant impact. By remaining deeply engaged throughout the lifecycle of their investments, Bharat Fund aims to significantly de-risk the conversion of innovative ideas into successful companies. The fund’s name, "Bharat," is inspired by the traditional name for India and reflects their dedication to fostering breakthrough innovations from the country. Their approach combines a decade of early-stage investing experience with support from key partners like Tata Trusts, enabling them to build a robust platform for nurturing high-potential startups.

Big Idea Ventures, founded in 2018, is a leading venture capital firm focusing on the alternative protein and food technology sectors. With over 110 early-stage investments, they have become the most active investor in FoodTech globally. The firm operates through its New Protein Fund and Generation Food Rural Partners fund, supporting innovative companies in plant-based, cell-based, and fermentation-enabled food technologies. Notable investments include companies like Naturannova, which creates sustainable peptide-based flavors using AI, and SoundEats, a cultivated seafood pioneer. Other standout portfolio companies are New Wave Biotech, which develops bioprocess optimization software, and Loki Foods, which produces plant-based seafood using renewable energy in Iceland. Big Idea Ventures runs bi-annual accelerator programs in New York, Paris, and Singapore, providing selected companies with a $200,000 investment and access to an extensive network of partners and investors. This hands-on support helps startups navigate product development, scaling, and market entry. Led by founder Andrew D. Ive, Big Idea Ventures collaborates with strategic partners like Temasek Holdings, Tyson Ventures, and Givaudan, aiming to drive significant advancements in food security and sustainability.

Big Pi Ventures is a venture capital firm based in Greece, focusing on seed and early-stage investments, particularly in deep-tech and science-driven startups. Established with a vision to drive transformative innovation, Big Pi partners with exceptional teams developing technologies that address significant global challenges. Their investments span various sectors, including artificial intelligence, health and life sciences, and climate technology, often targeting companies with strong intellectual property or technological advantages. The firm is anchored in Greece but maintains a global perspective, requiring that its portfolio companies establish substantial operations in Greece. Notable investments include companies like TileDB, Orfium, and Navenio, reflecting their commitment to backing ventures that have the potential to scale internationally. Big Pi is led by a team of seasoned entrepreneurs and investors, including Marco Veremis, co-founder of Upstream, and Alex Eleftheriadis, a pioneer in video compression technology. The team offers more than just capital, providing strategic support in areas like product design, scaling, and global market expansion. Their latest rebranding and new fund, announced in 2023, signify their ongoing commitment to fostering innovation and supporting the next generation of tech leaders.

BIGR Ventures, officially known as Boulder Investment Group Reprise, is a growth equity fund that focuses on early-stage investments in the natural and organic products sector. Founded in 2015 and headquartered in Boulder, Colorado, BIGR Ventures is led by a team with over 70 years of combined experience in the natural products industry. The firm is co-managed by Duane Primozich, Carole Buyers, and Bill Weiland, each bringing a wealth of knowledge in business management, brand development, and investment in the natural food and wellness sectors. BIGR Ventures strategically partners with emerging brands that have the potential for significant growth in the natural products space. Their portfolio includes well-known companies such as Bobo’s Oat Bars, High Brew Coffee, RE Botanicals, and Soozy’s Grain-Free, which have benefited from BIGR's extensive industry connections and expertise. The fund's approach emphasizes adding strategic value beyond just capital, helping portfolio companies scale through marketing, distribution, and operational support. The firm has a successful track record, with several notable exits, including REBBL and Suja Juice, which were acquired after achieving substantial market penetration. BIGR's investment philosophy is grounded in its deep understanding of the natural products industry, allowing it to identify and nurture brands that resonate with today’s health-conscious consumers.

BioAdvance is a prominent life sciences venture capital fund based in the mid-Atlantic region, focusing on therapeutics, diagnostics, medical devices, research tools, and health IT. With over 100 investments, they have achieved 23 exits and brought 12 FDA-approved products to market. Their portfolio companies, such as Palvella Therapeutics and Strados Labs, have attracted significant follow-on funding, collectively raising over $4.2 billion. BioAdvance operates as an evergreen fund, enabling continuous reinvestment and long-term partnership with entrepreneurs. The fund emphasizes capital efficiency and works closely with startups to maximize limited resources. Their investment strategy centers on advancing human health technologies with potential for high impact, targeting early-stage companies with scalable innovations. Led by a team of seasoned executives, scientists, and physicians, BioAdvance is collaborative, often playing an active role in company growth and guiding entrepreneurs toward successful exits via IPOs or acquisitions. They prefer to engage with startups that have a strong business case and well-developed pitch, ensuring a strong fit with their mission of improving human health.

Bioeconomy Capital is a San Francisco and Seattle-based venture capital firm founded in 2015. The firm focuses on early-stage investments in biotechnology, life sciences, and sustainability technology. Bioeconomy Capital is driven by the goal of accelerating the biotechnology revolution by supporting companies that are developing critical infrastructure and innovative technologies for the 21st century. With a strong foundation in synthetic biology, Bioeconomy Capital leverages decades of expertise in life sciences and engineering to back startups with transformative potential. The firm’s portfolio includes notable companies such as Zymergen, Riffyn, Synthace, RoosterBio, and Arzeda. Bioeconomy Capital typically invests between $100K and $5M, with a sweet spot of $1.5M per investment. The firm has a global focus, primarily investing in the U.S. but occasionally supporting companies in the U.K. and other regions. Led by managing directors Rob Carlson and Rik Wehbring, Bioeconomy Capital plays a strategic role in helping its portfolio companies navigate the complexities of scaling biotech and sustainability solutions​.

BioGeneration Ventures (BGV) is a prominent venture capital firm based in Naarden, Netherlands, specializing in early-stage European biotech companies. With over €400 million under management, BGV focuses on sectors like biopharma, medtech, and diagnostics. Their portfolio features notable investments in companies such as AcertaPharma, argenx, and New Amsterdam Pharma, underscoring their success in advancing groundbreaking scientific innovations and addressing unmet medical needs. BGV typically engages in seed to early growth stages, strategically guiding companies through clinical trials and drug development to achieve substantial exits. Their rigorous selection process ensures they back ventures with the highest potential for impactful outcomes. BGV's investment philosophy centers on combining deep scientific expertise with commercial insight to build world-class biotech firms. The firm is led by a team of experienced professionals, including managing partners Edward van Wezel and Suzanne Morsink, who bring extensive backgrounds in life sciences and venture capital. They actively support portfolio companies with strategic guidance, leveraging their broad network and industry knowledge to drive growth and innovation. BGV is committed to fostering the next generation of biotech leaders, with a clear focus on creating value for both investors and society by addressing critical health challenges through cutting-edge science and technology

BioMedPartners, through its BioMedInvest funds, focuses on venture capital investments in early to mid-stage companies in the biotechnology, pharmaceutical, and medical technology sectors. Based in Basel, Switzerland, the firm supports innovations primarily in the Alpine region and other European markets. Notable portfolio companies include Aleva Neurotherapeutics, developing next-generation implants for deep brain stimulation; Anergis, which focuses on peptide-based immunotherapies for allergies; and Evolva, a biotech firm creating sustainable ingredients for health and nutrition. Additionally, BioMedPartners has invested in companies like Hookipa Biotech, which develops novel immunotherapies for infectious diseases and cancer, and Sequana Medical, specializing in implantable fluid management systems. The BioMedPartners team is led by General Partners such as Dr. Markus Hosang and Dr. Michael Wacker, who bring extensive experience in drug development, finance, and technology. The firm takes an active role in the development of its portfolio companies, often leading investment rounds and participating as a syndicate partner​.

Bioqube Ventures is a specialist life sciences venture capital firm focused on early-stage investments in Europe, particularly in therapeutic assets and disruptive healthcare technologies. Founded in 2016 by Debora Dumont and Nico Vandervelpen, the firm launched its independent fund, Bioqube Factory Fund I, in 2020. This fund, which has secured over €60 million in its initial closing, aims to support the development of breakthrough therapies by leveraging Bioqube's unique dual investment model. This model includes both traditional venture investments and a "Create" strategy, which focuses on de-risking projects before establishing new ventures. The fund's strategy is deeply rooted in supporting high-potential scientific innovations, transforming them into commercially viable biotechnologies. Bioqube has strong partnerships with prominent investors like the European Investment Fund, Johnson & Johnson Innovation, and Genmab, further bolstering its ability to drive significant advancements in the life sciences sector. The Bioqube team is composed of experienced fund managers, sector experts, and serial entrepreneurs, bringing a hands-on approach to guiding portfolio companies through their growth stages. The firm has a significant presence in Europe, with a focus on regions such as the Benelux, France, and Germany, aiming to build a new generation of leading biotech companies.

Bioverge is a venture capital firm and investment platform specializing in early-stage healthcare startups. Based in San Francisco, Bioverge provides accredited investors with opportunities to invest in innovative healthcare companies that aim to transform the industry. The platform leverages deep domain expertise and a robust network to offer exclusive access to premier healthcare startups, ensuring that investments have both high impact and the potential for significant returns. Bioverge Funds, such as the Bioverge Access Fund, allow investors to diversify their portfolios by investing in a curated selection of healthcare startups through a single investment. These funds provide preferred access to deals, discounted fees, and the benefit of spreading investment risk across multiple companies. Bioverge emphasizes a data-driven investment approach, utilizing AI to select the most promising opportunities in the healthcare sector. Notable investments by Bioverge include companies like Enveda, which focuses on developing next-generation small-molecule therapeutics, and JelikaLite, which has created a non-invasive therapy for children with autism. Bioverge's investment strategy aims to support startups that offer groundbreaking solutions in healthcare, biotechnology, and medical technology. The firm was founded by Neil Littman, who brings extensive experience in healthcare venture capital. Bioverge's mission is to democratize access to high-quality healthcare investments, providing individual investors with the same opportunities as institutional investors.

BIP Ventures, previously known as Panoramic Ventures, is an Atlanta-based VC firm known for its mission of investing in underserved markets and underrepresented founders. With over $550 million in assets under management, BIP Ventures focuses on funding early-stage and growth-stage companies, particularly in the B2B software, healthcare, fintech, and tech-enabled services sectors. The firm takes a unique approach by targeting investments in regions often overlooked by traditional VCs, such as the Southeast and Midwest, and promoting diversity in its portfolio, prioritizing racial and gender inclusion. In addition to capital, BIP Ventures offers strategic support, including talent acquisition, operational scaling, and infrastructure to help portfolio companies grow into market leaders. The team, led by Mark Buffington and Paul Judge, consists of experienced investors and operators who have collectively backed over 200 startups, with several notable exits. The firm is also active in fostering innovation through university partnerships, investing in startups originating from academic institutions. BIP Ventures is known for initiatives like its Startup Showdown pitch competitions, which provide early-stage companies with funding opportunities. Entrepreneurs partnering with BIP Ventures benefit from a hands-on approach, with mentorship and resources to accelerate growth.

Bitkraft Ventures is a leading venture capital firm focused on gaming, esports, and interactive media. Founded in 2015 by Jens Hilgers, Bitkraft has established itself as a pioneer in the gaming and Web3 investment space. The firm invests globally, targeting early-stage companies from Seed to Series B rounds. Bitkraft's portfolio includes over 135 companies spanning six continents, with notable investments in startups like Flock Freight, FitXR, and Honeybee Health. The firm's latest fund, Bitkraft Venture Fund 3, has raised $275 million to continue supporting innovative gaming and interactive media companies. Bitkraft's investment strategy emphasizes the convergence of physical and digital worlds, a concept they refer to as "Synthetic Reality." This vision encompasses advancements in AI, VR/AR, and blockchain technologies, aiming to create immersive and interconnected experiences. The team at Bitkraft is comprised of experienced entrepreneurs and industry leaders, providing both capital and strategic guidance to their portfolio companies. With a global presence and deep industry connections, Bitkraft Ventures remains at the forefront of driving innovation in gaming and interactive media.

Bits x Bites is a Shanghai-based venture capital firm and China’s first dedicated agrifood tech investor. Founded in 2016 by Matilda Ho, the firm focuses on early-stage startups tackling the most critical challenges in the food system, including food security, safety, and sustainability. Their investments span the entire food supply chain, from farm innovations to novel food production technologies, helping to revolutionize agriculture in China and beyond. Bits x Bites manages over $100 million across its funds, with a strong emphasis on scalable technologies that can make a measurable impact on food production and environmental sustainability. Their portfolio includes companies like EAVision, which specializes in autonomous drones for complex farming terrains, and Mojia Bio, a biomanufacturing startup that produces eco-friendly nutrients for the food industry. These investments reflect the firm’s commitment to advancing solutions in precision agriculture, alternative proteins, and biomanufacturing. With a global outlook, Bits x Bites evaluates around 1,200 startups annually, targeting companies with technologies that can be applied in China. They support their portfolio companies through partnerships with industry leaders such as Syngenta and Temasek, offering access to valuable resources and markets. The firm’s multidisciplinary team of experts provides hands-on guidance to help startups scale and commercialize their innovations in the Chinese market, shaping the future of food technology in the region​.

Black Pearls VC is an early-stage venture capital firm based in Gdańsk, Poland, with a strategic focus on the Baltic Sea Region and Central Europe. They are particularly keen on deep tech startups developing unique, scalable technologies. The fund supports businesses from seed to Series A stages, with initial investments ranging from €100k to €1m and follow-on investments up to €3m. The firm has a sector-agnostic approach but has made significant strides in digital health, enterprise software, fintech, and deep tech. Notable portfolio companies include Nanoxo, a developer of non-toxic quantum dots for various industries; Xopero, specializing in data protection solutions; and Prosoma, which offers digital therapeutics for cancer patients​. Black Pearls VC's investment strategy emphasizes collaboration, often co-investing with other prominent funds. They focus on backing entrepreneurs with groundbreaking ideas and providing extensive support through their global network of advisors and partners. The team includes experts like Managing Partner Marcin P. Kowalik, who brings a wealth of experience in corporate finance and investment management. For startups looking to attract Black Pearls VC, it is essential to highlight the scalability and uniqueness of their technology. Approaching them through detailed pitches that align with their deep tech focus can significantly increase the chances of securing funding.

Black Star Fund is a venture capital firm founded to invest in and support high-growth, Black-led startups. Established with a mission to address the historic undercapitalization of Black founders, the firm believes these companies represent a unique asset class with the potential for outsized returns. Led by managing partner Kwame Anku, the fund primarily invests in the U.S. and focuses on companies in technology, consumer goods, media, and entertainment. Black Star Fund goes beyond providing capital. Their high-touch portfolio management approach offers extensive business development support and access to a wide network of decision-makers, helping founders scale quickly. The fund also leverages deep expertise in marketing and media to boost brand equity for its portfolio companies. With $12 million under management from its first fund, the firm has built a portfolio that includes 19 companies, 62% of which are led by Black women. Black Star Fund is actively raising capital for its second fund to continue investing in new opportunities.

Blackbird Ventures is a prominent venture capital firm based in Australia and New Zealand, known for its early-stage investments in startups with high ambitions and potential for generational impact. Founded in 2012, Blackbird has backed over 100 companies, including well-known names like Canva, Zoox, SafetyCulture, and Culture Amp. The firm is sector-agnostic, investing across various industries, from software to space technology. Blackbird's investment philosophy emphasizes supporting founders from the earliest stages, before revenue or product, through their entire journey to IPO and beyond. This approach has led to substantial success, with a portfolio valued at over $7 billion and several companies exceeding $1 billion in valuation. Blackbird is also committed to building a robust community around its portfolio companies, offering programs like Giants, a mentoring initiative, and The Sunrise festival, which fosters a vibrant startup ecosystem. Their team consists of experienced investors and industry professionals dedicated to helping founders achieve their wildest ambitions.

Blackhorn Ventures is an early-stage venture capital firm that focuses on investing in companies that drive industrial efficiency and environmental sustainability. The firm targets sectors such as energy, construction, supply chain logistics, and transportation. Some of the notable portfolio companies include Aperia, which develops tire inflation systems for trucks; Agorus, known for building custom homes quickly and precisely; and Electric Era, which creates advanced energy storage systems for EV charging stations. Blackhorn Ventures employs a capital-efficient approach, leveraging AI and digital solutions to modernize traditional industries and improve operational efficiency. The firm is deeply committed to decarbonizing industry sectors and aligning investments with environmental sustainability goals. The firm is led by experienced investors and operators who focus on creating value and engaging collaboratively with their portfolio companies and strategic partners to achieve both financial returns and impactful outcomes.

Blank Slate Ventures is a seed-stage venture capital firm based in Chattanooga, Tennessee. Founded in 2011 by Lex Tarumianz and Sheldon Grizzle, the firm focuses on investing in pre-revenue startups within the Chattanooga region. Their primary investment areas include software, SaaS, esports, gaming, TMT (technology, media, and telecommunications), and media sectors. Blank Slate Ventures typically invests in early-stage companies, with initial investments ranging from $5,000 to $100,000. The firm has a strong emphasis on helping startups disrupt their respective industries, providing not just capital but also strategic support to transform innovative ideas into viable businesses. Notable investments include companies like Quickcue, which was later acquired by OpenTable, and Rezli​. For entrepreneurs looking to partner with Blank Slate Ventures, highlighting the potential for significant industry disruption and demonstrating strong growth potential can be key to securing investment. The firm’s focus on early-stage, pre-revenue startups makes it an ideal partner for new ventures in need of both funding and strategic guidance.

Blindspot Ventures is a seed-focused venture capital firm based in Boston, specializing in backing visionary founders who are reshaping industries through platform technologies and infrastructure innovation. The firm is known for partnering with bold, iconoclastic entrepreneurs who challenge the status quo and develop foundational technologies that drive industry evolution. Their portfolio includes cutting-edge companies like Form Energy, Mori, bloXroute, and Volta Labs, all of which are pioneers in fields ranging from renewable energy storage to advanced material science. Blindspot primarily invests in early-stage companies, with a typical check size of $500K to $3M. Their geographic focus is predominantly on the U.S., leveraging Boston’s rich history of innovation and proximity to top-tier academic institutions. Blindspot actively supports its portfolio companies, often taking board seats and offering strategic advice to foster long-term partnerships. Led by managing partners Ahmed Hentati and Hassan Dayekh, Blindspot is driven by a passion for addressing critical global challenges. Hentati, deeply ingrained in Boston’s startup ecosystem, focuses on identifying and backing groundbreaking founders, while Dayekh manages operations and co-leads the investment committee, bringing extensive experience from his background in banking and growth-stage venture capital.

Bling Capital is a venture capital firm specializing in seed-stage investments, founded by Ben Ling, who has a strong track record with 19 "unicorn" investments. The firm focuses on helping entrepreneurs achieve product-market fit and scale their businesses. Bling Capital has recently announced the closing of its third fund, raising $212 million, which includes a $109 million core seed fund and a $103 million opportunity fund to support companies as they grow. The firm's investment strategy targets sectors such as B2B software, consumer tech, digital health, fintech, and the future of work. Bling Capital typically invests around $1 million at the seed stage and provides extensive support through its Product Council, which comprises over 100 top product leaders from various industries. Notable companies in Bling Capital's portfolio include Lyft, Palantir, Lucidchart, Udemy, Gusto, and Instacart. The firm is dedicated to partnering with high-potential founders and supporting them through every stage of their journey.

Blisce is a transatlantic growth-stage venture capital firm founded by Alexandre Mars in 2014, with offices in New York and Paris. It focuses on mission-driven entrepreneurs, backing companies that aim to create a positive impact, particularly in the consumer technology sector. Blisce is notable for being the first VC fund to earn B Corp certification, reflecting its commitment to sustainability and social responsibility. The firm typically invests in Series A to C rounds, with check sizes ranging from $5 million to $30 million. Its portfolio includes prominent names like Spotify, Pinterest, Headspace, and Too Good To Go. Blisce’s investment focus spans across sectors such as e-commerce, digital health, financial services, and climate tech, with recent efforts concentrating on trends like healthcare consumerization, generative AI, and sustainability. Blisce stands out for its impact-oriented approach, helping its portfolio companies implement ESG strategies, and requiring them to report on their sustainability goals. Additionally, 20% of the firm’s carried interest is pledged to charitable causes, including Mars's Epic Foundation, which supports youth and climate initiatives.

Bloc Ventures is a specialist deep tech investor founded in 2013 by Bruce Beckloff and David Leftley, both veterans of ARM and Vodafone. The firm focuses on early-stage investments in European deep tech companies, particularly those working in cloud computing, connectivity, data science, and security. They aim to support ambitious entrepreneurs building products with the potential to impact entire industries. Bloc Ventures has a robust portfolio of companies, including Helix Geospace (precision antennas), Mindtrace (AI software), Paytia (cloud-based PCI compliance solutions), Pharrowtech (RF semiconductor technology), and Shield-IoT (IoT security platform). These investments highlight Bloc's commitment to advancing technologies that enable significant industry advancements. The firm recently raised over €23.9 million to fund early-stage deep tech startups in Europe, led by IPGL Limited and supported by industry leaders. This funding will support new portfolio additions and follow-on investments, aligning with Bloc’s strategy to scale companies of global significance. Bloc Ventures is headquartered in London and is recognized for its expert-led funding approach, combining technological, commercialization, and financial expertise to help startups reach their full potential. The team includes professionals with extensive backgrounds in the tech industry, venture capital, and company management, ensuring a hands-on and supportive partnership for their portfolio companies​

Bloomberg Beta, an early-stage venture capital firm launched in 2013, manages $375 million in total across several funds. Backed solely by Bloomberg L.P., the firm focuses on investing in startups that aim to improve the future of work, emphasizing machine intelligence and data-centric technologies. Notable investments include companies such as Repl.it, a cloud computing platform for developers; LaunchDarkly, which helps software teams build better software faster; and StrongDM, an infrastructure access platform. Bloomberg Beta has also had significant exits, including Rigetti Computing, Orbital Insight, and Flashpoint​. The firm operates independently from Bloomberg L.P., and its team, led by Roy Bahat, Karin Klein, and James Cham, employs a unique investing model where any team member can independently approve deals. They maintain a strong commitment to transparency, with their operating manual and investment criteria publicly available on GitHub​​. Bloomberg Beta supports entrepreneurs through various stages of growth, leveraging data to identify potential founders and emphasizing a collaborative approach to investment. Their investment strategy is broad, focusing on startups that can bring transformative changes to how businesses operate and how people work

Blossom Capital, founded in 2017 and headquartered in London, has quickly established itself as a leading Series A investor in Europe. Led by Ophelia Brown, Imran Ghory, and Alex Lim, Blossom Capital focuses on high-potential sectors such as fintech, consumer internet, Web3, and enterprise SaaS. Notable investments include Moonpay, Checkout.com, Fat Llama, and Tines, demonstrating their knack for backing innovative startups. Blossom's strategy emphasizes deep, hands-on involvement, limiting investments to 5-6 Series A rounds per year to provide focused support. This approach includes assisting with recruitment, go-to-market strategies, and subsequent fundraising efforts. They prioritize building strong, long-term relationships with founders, often spending months getting to know them before committing to an investment​. The firm has a robust track record, with portfolio companies like Checkout.com and Moonpay achieving significant growth and valuations. Blossom's $432 million third fund, raised from prominent US and European investors, underscores their commitment to nurturing Europe's tech ecosystem​. For startups seeking to partner with Blossom, the key is demonstrating a clear vision and potential for substantial market impact. They value founders who are not only innovative but also resilient and prepared to scale efficiently. Blossom’s team, known for their rigorous support and strategic insight, is dedicated to propelling their portfolio companies to new heights.

Blu Venture Investors is a proactive venture capital fund that excels in early-stage investments, focusing on cybersecurity, healthtech, and B2B SaaS. With notable investments in startups such as Urgently, Interfolio, and Avizia, Blu Venture has a strong track record of supporting companies poised for growth​. The fund is geographically focused on the Mid-Atlantic region of the United States, providing strategic support and funding primarily to companies within this area. Their investment strategy is characterized by a hands-on approach, leveraging their team’s entrepreneurial experience to mentor and guide founders. They typically invest between $250,000 and $2 million per company, often leading the investment rounds and taking active roles in guiding company strategy and development. Blu Venture Investors prides itself on a founder-aligned approach, prioritizing long-term relationships and operational support. The team comprises seasoned entrepreneurs and industry operators who understand the challenges of building a business and offer valuable insights and mentorship to their portfolio companies. This commitment is reflected in their active involvement in portfolio companies' growth and success​ (Blu Ventures)​. Overall, Blu Venture Investors is an ideal partner for early-stage startups looking for more than just capital. Their approach combines financial support with strategic guidance, ensuring that their portfolio companies have the resources and expertise needed to succeed in a competitive market​.

Blue Bear Ventures (BBV) is a venture capital firm focused on deep tech innovations emerging from top research institutions, especially within the University of California system. Founded in 2017, BBV backs startups at the frontier of science and technology, particularly in areas like AI, synthetic biology, energy, and gene therapy. They work closely with founders who are often scientists and engineers, helping translate cutting-edge research into scalable businesses. The firm builds on its roots in the CITRIS Foundry accelerator at UC Berkeley, where it has nurtured groundbreaking startups. BBV typically invests in early-stage companies, emphasizing the impact of technology on sectors such as healthcare, energy infrastructure, and materials science. Some of their portfolio companies include Ayar Labs (optical data transmission), Clarity (air quality monitoring), and Coreshell (battery nanotechnology)​. BBV is committed to supporting deep tech entrepreneurs through a combination of financial investment and hands-on guidance, fostering startups that aim to solve global challenges.

Blue Collective is a multi-strategy venture capital firm based in Brooklyn, New York, that prioritizes investing in exceptional people and groundbreaking ideas. Founded in 2014 by JJ Kasper and Brian Stafford, the firm focuses on early-stage investments across a variety of sectors, including consumer products, B2B services, enterprise software, and healthtech. Notable investments include Unqork, Tecovas, ZocDoc, MediaMath, and Catalina Crunch, showcasing their diverse portfolio. Blue Collective typically writes checks ranging from $250K to $2 million and prefers to follow rather than lead funding rounds. However, they are willing to step in as lead investors if they have strong conviction in the opportunity. The firm's investment strategy emphasizes deep and ongoing engagement with founders, offering support in strategic, operational, and technical areas to help businesses scale. Blue Collective prides itself on maintaining a transparent and efficient decision-making process, involving all team members, from partners to associates, in the investment decisions. With a focus on strong, long-term relationships, Blue Collective supports their portfolio companies through introductions, advice, and an annual retreat to foster a community among their founders. They maintain a people-first approach, prioritizing the growth and well-being of their team and stakeholders. Overall, Blue Collective is committed to backing phenomenal entrepreneurs and building innovative businesses that have the potential to make a significant impact​.

Blue Horizon is a Zurich-based venture capital firm focused on investing in the future of food. Founded in 2016 by Bjoern Witte and Roger Lienhard, the firm has established itself as a leader in the sustainable food sector, managing over $850 million in assets and investing in more than 60 companies globally. The firm primarily targets the alternative protein and food technology industries, with notable investments in companies like Impossible Foods, Mosa Meat, and Planted. These investments reflect Blue Horizon's commitment to pioneering innovations that promote sustainability and environmental responsibility. Mosa Meat, for instance, developed the world’s first lab-grown beef burger, while Planted is a notable player in the vegan meat market. Blue Horizon’s investment strategy emphasizes a full lifecycle approach, supporting companies from seed stage through to significant growth phases. They focus on businesses that offer transformative solutions to global challenges in the food system, such as reducing reliance on traditional meat and dairy production, and promoting plant-based and cultured food alternatives. For startups looking to connect with Blue Horizon, demonstrating a strong alignment with their mission of creating a sustainable food system and showcasing innovative solutions that address significant market opportunities are key to forming a successful partnership.

Blue Haven Initiative is a pioneering family office focused on combining competitive financial returns with deep social and environmental impact. Co-founded by Liesel Pritzker Simmons and Ian Simmons in 2012, it manages a diverse portfolio across asset classes including public equities, private equity, fixed income, and direct investments. The initiative targets sectors such as clean energy, financial inclusion, and healthcare, with notable investments in companies like CrossBoundary, PEG Africa, and M-Kopa. Geographically, Blue Haven has a significant focus on Sub-Saharan Africa, where it supports early-stage businesses that create economic opportunities and improve living standards in underserved communities. Their strategy includes not only market-rate investments but also philanthropic efforts, policy advocacy, and coalition-building to drive systemic change. As an active early-stage investor, Blue Haven often leads rounds, leveraging its flexibility as a family office to deploy catalytic capital where needed. Ian Simmons, a champion of long-term, impactful investing, leads the team from their headquarters in Cambridge, Massachusetts, working closely with external partners to maximize both financial and social returns.

BluePointe Ventures, founded in 2014 and based in San Mateo, California, is a venture capital arm of BluePointe Capital Management. The firm primarily invests in innovative companies within the sectors of artificial intelligence, augmented reality, virtual reality, big data, and cloud/SaaS. Notable investments include ClassPass, Pipedrive, and Palantir Technologies, with successful exits from companies like Postmates and Nextdoor. BluePointe Ventures focuses on early to growth-stage startups and typically makes investments ranging from seed to Series A. They prefer to fund companies that demonstrate potential for significant technological advancement and market impact. The firm is particularly active in North America but also explores opportunities globally. Their investment strategy includes a mix of direct investments and participation in micro VC funds. They emphasize partnering with founders who leverage frontier technology to enhance human experiences. The fund's average investment size is around $6 million, and they have a track record of leading rounds, especially in their peak activity years like 2021. The leadership team at BluePointe Ventures includes Co-Founder and Managing Director Sandeep Sardana, CEO Sanjeev Sardana, and COO Laura Baverman, all of whom bring substantial experience in venture capital and strategic investments. For startups seeking investment, BluePointe Ventures values innovative solutions that align with their focus on transformative technologies. Entrepreneurs are advised to approach them with a clear demonstration of how their technology can create significant market disruptions and drive long-term growth​.

BlueRun Ventures (BRV), founded in 1998 and headquartered in Menlo Park, CA, is an early-stage venture capital firm with a global presence. The firm has offices in the United States, China (Beijing and Shanghai), and South Korea. BRV is known for its focus on mobile, fintech, digital health, and consumer experiences, targeting startups that solve significant problems in these sectors. BRV's portfolio boasts notable investments including PayPal, Waze, Coupa, and Kabbage, showcasing their track record in identifying and nurturing high-potential companies. The firm’s investment strategy involves leading seed and Series A rounds, typically investing between $2 million and $8 million per deal. They prioritize early-stage companies that exhibit strong growth potential and innovative solutions. The BRV team consists of experienced professionals such as co-founders John Malloy and Jonathan Ebinger, who bring deep expertise in mobile software, services, and financial technology. The team leverages its collective experience in product development, marketing, and design to support portfolio companies. Startups looking to engage with BRV should emphasize their potential for disruption and scalability. The firm values entrepreneurs who are pushing industry boundaries and can benefit from BRV’s extensive network and hands-on approach to growth.

BlueYard Capital is a venture capital firm that invests in early-stage companies with transformative potential across various industries. Established to support innovative founders, BlueYard focuses on creating a future where markets are open and decentralized, significant planetary challenges are addressed, and knowledge and data are liberated. The firm is known for its thematic investments in sectors like blockchain, crypto, artificial intelligence, web3, and biotechnology. BlueYard has a diverse portfolio that includes companies such as Bit Bio, Meatable, and Biofidelity, which are involved in biotechnology and healthcare innovations. The firm also invests in blockchain and crypto platforms like Centrifuge and Agnostic, aiming to revolutionize data management and financial systems. The firm's investment strategy emphasizes backing open-ended, breakthrough research and early-stage startups. BlueYard's portfolio companies benefit from its extensive network, strategic guidance, and a supportive investment environment that fosters innovation and growth.

Blumberg Capital is an early-stage venture capital firm that invests in startups from inception through growth stages. With over $650 million in assets under management, the firm focuses on sectors such as fintech, AI, cybersecurity, enterprise software, and digital health. Blumberg Capital has been a key player in supporting companies that use transformative technologies to empower individuals and businesses. Notable investments include Nutanix, BioCatch, and DoubleVerify, demonstrating their success in various tech-driven industries. Additionally, Blumberg Capital has heavily invested in fintech companies, making up about 29% of their portfolio. Key fintech investments include Fundbox, Lendio, and Addepar. The firm is known for its hands-on approach, providing not just capital but also strategic support, leveraging its extensive network and expertise to help startups succeed. Blumberg Capital's investment strategy involves leading seed and Series A rounds, with initial investments ranging from $500,000 to $5 million. They are committed to partnering with visionary entrepreneurs and helping them navigate the challenges of scaling their businesses. The firm operates internationally, with offices in Miami, New York, San Francisco, and Tel Aviv. Their approach and successful track record make Blumberg Capital a prominent player in the venture capital landscape, supporting innovative companies that are shaping the future through technology​.

bmp Ventures is a seasoned venture capital firm based in Berlin, Germany, with over 25 years of experience in early-stage and growth investments. Since its founding in 1997, bmp Ventures has managed 11 venture capital funds and made more than 250 investments, resulting in over 120 exits and more than 20 IPOs. The firm focuses on investing in innovative and scalable companies across various sectors, including digital solutions, industry & deeptech, media & gaming, life sciences & eHealth, cleantech & planet positive, mobility & automotive, and fintech & legaltech​. They typically invest between €350,000 to €3 million in seed and early-stage rounds, with the potential to invest up to €10 million per company through subsequent financing rounds. bmp Ventures is known for being a hands-on investor, providing extensive support to their portfolio companies. This includes strategic advice, networking opportunities, assistance with business model refinement, and guidance on fundraising and exit strategies​.

BMW i Ventures is a venture capital firm focused on investing in innovative startups that shape the future of mobility and sustainability. Established in 2011, the firm has made over 50 investments in various sectors including transportation, manufacturing, supply chain, and sustainability. Their investment strategy covers a broad spectrum from seed to growth stages, with a focus on Series A and B rounds. Key portfolio companies include ChargePoint, a leading electric vehicle charging network; Solid Power, which develops solid-state battery technology; and Recogni, which designs power-efficient inference engines for edge-based sensors. Other notable investments include Proterra (electric buses), PureCycle (plastic recycling), and Tekion (automotive retail platform). BMW i Ventures recently announced the creation of a new $300 million fund aimed at early to mid-stage startups operating in sustainability and related sectors. This fund, BMW i Ventures' second, continues their commitment to advancing frontier technologies in the automotive sector while emphasizing environmental responsibility.

Boehringer Ingelheim Venture Fund (BIVF) is a dynamic venture capital arm of Boehringer Ingelheim, investing in groundbreaking biotechnologies and therapeutics. BIVF's notable portfolio includes companies like HepaRegenix, focusing on liver regeneration; Imcheck Therapeutics, developing novel cancer immunotherapies; and Asgard Therapeutics, pioneering gene therapy-mediated cancer treatments. BIVF primarily targets biotech startups in areas such as oncology, regenerative medicine, infectious diseases, and digital health, with a strong emphasis on early-stage investments. They invest globally, with significant activity in Europe, the US, and Asia, aiming to foster innovation that aligns with Boehringer Ingelheim's strategic interests. Their strategy involves taking minority stakes and actively supporting companies through the pre-seed, seed, and series A stages. BIVF typically leads funding rounds, providing crucial support in both capital and expertise. They prefer startups that are exploring novel therapeutic approaches with the potential for significant clinical impact. For startups looking to engage with BIVF, it’s essential to have a groundbreaking technology with strong preclinical or early clinical data. They value strategic alignment with Boehringer Ingelheim’s therapeutic areas and appreciate a collaborative approach from entrepreneurs.